var data={"title":"Eosinophil biology and causes of eosinophilia","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Eosinophil biology and causes of eosinophilia</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/contributors\" class=\"contributor contributor_credentials\">Peter F Weller, MD, MACP</a></dd><dd><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/contributors\" class=\"contributor contributor_credentials\">Amy D Klion, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/contributors\" class=\"contributor contributor_credentials\">Donald H Mahoney, Jr, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/contributors\" class=\"contributor contributor_credentials\">Bruce S Bochner, MD</a></dd><dt><span> </span>Deputy Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/contributors\" class=\"contributor contributor_credentials\">Alan G Rosmarin, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/contributors\" class=\"contributor contributor_credentials\">Anna M Feldweg, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 05, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H17149461\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Eosinophils are predominantly tissue-dwelling cells whose functions in health are not entirely understood. Eosinophils in the peripheral blood or tissues can increase in a wide array of disease states, ranging in severity from mild to life-threatening, and as a result of several mechanisms. When activated, eosinophils are capable of releasing mediators and substances that can damage tissues and contribute to disease pathology.</p><p>Normal eosinophil biology, the mechanisms of eosinophilia, tissue damage by eosinophils, and the major causes of eosinophilia are discussed in this topic review. An approach to the patient with eosinophilia and the diagnosis and management of the hypereosinophilic syndromes are reviewed separately. (See <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;</a> and <a href=\"topic.htm?path=hypereosinophilic-syndromes-clinical-manifestations-pathophysiology-and-diagnosis\" class=\"medical medical_review\">&quot;Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis&quot;</a> and <a href=\"topic.htm?path=hypereosinophilic-syndromes-treatment\" class=\"medical medical_review\">&quot;Hypereosinophilic syndromes: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H199339678\"><span class=\"h1\">EOSINOPHIL BIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Eosinophils are white blood cells (WBCs) of the granulocytic lineage, which also includes neutrophils and basophils [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/1\" class=\"abstract_t\">1</a>]. The true physiologic function(s) of eosinophils remain largely unknown although they are likely involved in host immune response to infection, tissue remodeling, tumor surveillance, and maintenance of other immune cells [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/2\" class=\"abstract_t\">2</a>]. Eosinophils develop and differentiate in the bone marrow under the influence of interleukin (IL)-5, IL-3, and granulocyte-macrophage colony-stimulating factor (GM-CSF) [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/3\" class=\"abstract_t\">3</a>].</p><p class=\"headingAnchor\" id=\"H347120257\"><span class=\"h2\">Normal levels</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In peripheral blood, an absolute eosinophil count (determined by multiplying the total WBC count by the percentage of eosinophils) of 0 to 500 <span class=\"nowrap\">cells/microL</span> (&lt;0.5 x 10<sup>9</sup><span class=\"nowrap\">/L)</span> is typically considered normal. Defining the normal range by percentage of WBC can be problematic because differences in absolute neutrophil counts between ethnic groups can dramatically impact the percent of eosinophilia [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/4\" class=\"abstract_t\">4</a>]. Blood eosinophil counts have been reported to vary within the same person at different times of day and on different days, both in individuals with eosinophilic disorders and in healthy volunteers [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/5-7\" class=\"abstract_t\">5-7</a>]. However, results are inconsistent among studies, and the variability in counts is rarely large enough to impact care.</p><p>Eosinophils are primarily tissue-dwelling cells; they are several hundred-fold more abundant in tissues than in blood [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/8\" class=\"abstract_t\">8</a>]. In healthy individuals, eosinophils can be found in the spleen, lymph nodes, thymus, and digestive tract (although not the esophagus) [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/2\" class=\"abstract_t\">2</a>]. Recruitment of eosinophils to these tissues is mediated mainly by eotaxins, a family of chemokines (ie, cytokines that stimulate cell migration) that bind to the eosinophil chemokine receptor CCR3.</p><p class=\"headingAnchor\" id=\"H17149701\"><span class=\"h2\">Mechanisms of eosinophilia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>An increase in eosinophils in the peripheral blood or tissues can result from different mechanisms:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Polyclonal expansion</strong> &ndash; A polyclonal expansion of eosinophils may result from overproduction of IL-5. This is termed reactive or secondary eosinophilia. Sufficient quantities of IL-5 to cause eosinophilia can be produced by T helper cell type 2 (T<sub>h</sub>2) lymphocytes and group 2 innate lymphoid cells (ILC-2) in the setting of helminthic infections [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/9-11\" class=\"abstract_t\">9-11</a>], allergen exposure, and certain organ-specific diseases like eosinophilic granulomatosis with polyangiitis (EGPA), eosinophilic gastrointestinal disorders or nasal polyposis, or constitutively by malignant cells from solid tumors (usually adenocarcinomas), T cell lymphomas, or Hodgkin lymphomas [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/2\" class=\"abstract_t\">2</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Clonal expansion</strong> &ndash; Less commonly, clonal eosinophilia arises as a result of a hematopoietic stem cell mutation. In this case, eosinophils may be the predominant cell type involved (eg, acute or chronic eosinophilic leukemia) or one of several proliferating cell lines (eg, chronic myelomonocytic leukemia or systemic mast cell disease).</p><p/><p>Certain common disorders result in a <strong>decrease</strong> in eosinophil numbers. Fever, bacterial and viral infections, and systemic glucocorticoid administration can all dramatically suppress blood eosinophil counts.</p><p class=\"headingAnchor\" id=\"H199339794\"><span class=\"h2\">Tissue damage</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tissue damage is more likely to occur when the absolute eosinophil count exceeds <span class=\"nowrap\">1500/microL</span> but can occur even with lower blood eosinophil levels [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/2,12,13\" class=\"abstract_t\">2,12,13</a>]. <strong>It is important for the clinician to understand that the degree of peripheral blood eosinophilia does not always accurately predict the risk of organ damage.</strong> Thus, organ involvement and end-organ damage cannot be predicted by a high eosinophil count, nor can they be excluded by a normal eosinophil count.</p><p>Activated eosinophils may damage tissues by a number of mechanisms, including the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Release of toxic granule products (eg, major basic protein, eosinophil-derived neurotoxin, eosinophil peroxidase, or eosinophil cationic protein) that can damage epithelial cells and nerves.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Production of lipid mediators, such as sulfidopeptide leukotrienes and platelet activating factor, which mediate smooth muscle contraction and recruitment of inflammatory cells.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Release of cytokines such as GM-CSF, transforming growth factors (TGF)-alpha and -beta, and interleukins, which may be involved in tissue remodeling and fibrosis.</p><p/><p>These mediators are generally released after entry of eosinophils into tissues, although detection of eosinophil granule proteins in the blood is considered a potential biomarker of tissue eosinophilia. In some cases, increased blood levels of eosinophil granule proteins can be detected in the absence of peripheral eosinophilia in patients with eosinophilic tissue infiltration [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/14\" class=\"abstract_t\">14</a>].</p><p class=\"headingAnchor\" id=\"H199339842\"><span class=\"h3\">Target organs</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Common target organs of eosinophils in disease include the skin, airway, and gastrointestinal tract. However, cardiac and nervous system damage can also occur and can be more concerning and potentially life-threatening. (See <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H199339848\"><span class=\"h1\">MAJOR CAUSES OF EOSINOPHILIA</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There are various approaches to categorizing the disorders that can cause eosinophilia. In medical training, it is common to learn the mnemonic NAACP, which stands for <strong>N</strong>eoplasms, <strong>A</strong>ddison's disease, <strong>A</strong>llergic diseases, <strong>C</strong>ollagen vascular diseases, and <strong>P</strong>arasitic diseases. However, this approach has several limitations: Addison's disease is a rare cause but features prominently in the mnemonic; other groups of disorders, such as the eosinophilic gastrointestinal diseases and the hypereosinophilic syndromes (HES), do not fit well into any of the categories; and there are other infections besides parasitic infections that cause eosinophilia.</p><p>We prefer to divide the disorders into two groups because of differences in treatment approaches:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Disorders presenting with signs and symptoms affecting multiple organ systems, usually accompanied by peripheral blood eosinophilia (<a href=\"image.htm?imageKey=ID%2F76434\" class=\"graphic graphic_table graphicRef76434 \">table 1</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Disorders that typically present with eosinophilic involvement of a single organ, variably accompanied by peripheral blood eosinophilia (<a href=\"image.htm?imageKey=ID%2F84016\" class=\"graphic graphic_table graphicRef84016 \">table 2</a>)</p><p/><p>However, since some individuals who appear to have single-organ involvement may subsequently develop additional clinical manifestations, the division between these two groups is imperfect.</p><p class=\"headingAnchor\" id=\"H347121734\"><span class=\"h2\">Importance of considering many possible causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The degree of eosinophilia is rarely helpful for identifying the cause, except at extremes of eosinophil counts (eg, very mild eosinophilia is more likely to be seen with asthma or allergic rhinitis; severe eosinophilia [eg, &ge;20,000 <span class=\"nowrap\">eosinophils/microL]</span> is more likely to be caused by a myeloid neoplasm [MN]). Between these extremes, the list of potential causes is extensive and the clinician should consider the entire spectrum of disorders discussed here. An approach to the evaluation is reviewed elsewhere. (See <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;</a>.)</p><p>The pattern of organ involvement may be helpful in suggesting the etiology of eosinophilia in some patients (eg, serpiginous skin eruptions in cutaneous larva migrans; eosinophilic hepatitis in tetracycline-induced drug hypersensitivity). However, the presence or absence of organ dysfunction cannot be used to exclude a specific diagnosis.</p><p class=\"headingAnchor\" id=\"H199339877\"><span class=\"h3\">Neoplastic diseases</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Many neoplastic disorders can cause eosinophilia. Examples include the following:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Primary (or neoplastic) hypereosinophilic syndrome (HES)</strong> &ndash; Primary (neoplastic) HES refers to an MN that produces a predominance of mature eosinophils. In males, these are typically associated with an interstitial deletion resulting in the fusion gene, Fip1-like 1 (<em>FIP1L1</em>)-platelet-derived growth factor receptor alpha (<em>PDGFRA</em>). Other molecular abnormalities have also been implicated, including fusion genes involving platelet-derived growth factor receptor beta (<em>PDGFRB</em>) and fibroblast growth factor receptor (<em>FGFR1</em>). Other recurrent abnormalities include fusion genes and point mutations involving <em>JAK2</em>, which encodes the JAK2 protein kinase [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/15\" class=\"abstract_t\">15</a>]. Depending on the stage of their disease and the organ(s) involved, patients may present with few or no clinical manifestations or as an acutely ill, hospitalized patient. (See <a href=\"topic.htm?path=hypereosinophilic-syndromes-clinical-manifestations-pathophysiology-and-diagnosis#H7\" class=\"medical medical_review\">&quot;Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis&quot;, section on 'Myeloid HES variants'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Acute eosinophilic leukemia</strong> &ndash; Eosinophilic leukemia is a rare variant of acute myeloid leukemia (acute myelomonocytic leukemia with eosinophilia, formerly classified as FAB M4Eo) caused by abnormalities in chromosome 16. Patients usually present with symptoms related to complications of pancytopenia (eg, severe fatigue, infection, bleeding). Immature eosinophils may be seen in the peripheral blood. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-acute-myeloid-leukemia\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia&quot;</a> and <a href=\"topic.htm?path=cytogenetics-in-acute-myeloid-leukemia#H993131070\" class=\"medical medical_review\">&quot;Cytogenetics in acute myeloid leukemia&quot;, section on 'Inv(16) and t(16;16)'</a>.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chronic eosinophilic leukemia</strong> &ndash; Chronic eosinophilic leukemia (CEL) is a rare MN characterized by clonal expansion of dysplastic eosinophils. Patients may be asymptomatic or have constitutional symptoms. A variety of genetic abnormalities have been described in CEL. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-myeloid-leukemia#H14\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic myeloid leukemia&quot;, section on 'Chronic eosinophilic leukemia'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other myeloid</strong> <strong>neoplasms</strong> &ndash; Eosinophilia can be associated with a variety of other MNs. As examples:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Chronic myeloid leukemia (CML) is a myeloproliferative neoplasm associated with the <em>BCR-ABL1</em> fusion gene. Patients may be asymptomatic at diagnosis, while others present with fatigue, weight loss, or abdominal fullness due to splenomegaly. The predominant hematologic finding is an abundance of neutrophils and neutrophil precursor cells, but increased numbers of eosinophils are also commonly seen. It is rare for CML to present with a predominance of eosinophils over neutrophils. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-myeloid-leukemia#H5\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of chronic myeloid leukemia&quot;, section on 'Peripheral blood'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Systemic mastocytosis</strong> &ndash; Systemic mastocytosis (SM) is a clonal proliferation of mast cells that can infiltrate various organs including the skin, liver, spleen, bone marrow, and lymph nodes. Aggressive and indolent forms exist. Patients may present with signs and symptoms of recurrent &quot;allergic&quot; reactions caused by episodic release of mast cell mediators or with organomegaly, hematologic, or cutaneous abnormalities (most commonly urticaria pigmentosa) (<a href=\"image.htm?imageKey=RHEUM%2F63025\" class=\"graphic graphic_picture graphicRef63025 \">picture 1</a>). Peripheral blood eosinophilia is seen in up to 20 percent of cases. (See <a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-evaluation-and-diagnosis-in-adults\" class=\"medical medical_review\">&quot;Mastocytosis (cutaneous and systemic): Evaluation and diagnosis in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Lymphoid neoplasms</strong> &ndash; Almost any B or T cell lymphoma or leukemia can be implicated in causing eosinophilia. The mechanism may involve dysregulation of cytokine production by lymphocytes. Some lymphoid neoplasms commonly associated with eosinophilia include the following:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>B cell lymphoma</strong> &ndash; Hodgkin lymphoma and B cell non-Hodgkin lymphoma (NHL) can be associated with eosinophilia; one report suggested that eosinophilia could occur in up to 15 percent of patients with Hodgkin lymphoma and 5 percent of those with B cell NHL [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/16\" class=\"abstract_t\">16</a>]. Patients present with lymphadenopathy with or without &quot;B symptoms&quot; (eg, fever, weight loss, sweats). (See <a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">&quot;Clinical presentation and diagnosis of non-Hodgkin lymphoma&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>T cell lymphoblastic lymphoma and adult T cell <span class=\"nowrap\">leukemia/lymphoma</strong></span> &ndash; T cell malignancies including lymphoblastic lymphoma, T cell <span class=\"nowrap\">leukemia/lymphoma,</span> and angioimmunoblastic T cell lymphoma (AITL) have also been associated with eosinophilia. Patients are generally acutely ill. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-peripheral-t-cell-lymphoma-not-otherwise-specified#H3\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified&quot;, section on 'Clinical features'</a> and <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-angioimmunoblastic-t-cell-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of angioimmunoblastic T cell lymphoma&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>S&eacute;zary syndrome</strong> &ndash; S&eacute;zary syndrome is a type of cutaneous T cell lymphoma (CTCL) associated with increased serum immunoglobulin E (IgE) and eosinophilia. Patients can present with erythroderma, lymphadenopathy, and systemic symptoms. (See <a href=\"topic.htm?path=clinical-presentation-pathologic-features-and-diagnosis-of-sezary-syndrome#H449461398\" class=\"medical medical_review\">&quot;Clinical presentation, pathologic features, and diagnosis of S&eacute;zary syndrome&quot;, section on 'Pathogenesis'</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span><strong>Precursor B cell acute lymphoblastic leukemia </strong>&ndash; Acute lymphoblastic leukemia (ALL) with a t(5;14) translocation has been associated with eosinophilia. This translocation causes fusion of the immunoglobulin heavy-chain gene to the <em>IL3</em> gene promoter. Eosinophilia may be an early presenting sign prior to the development of clinical manifestations [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/17,18\" class=\"abstract_t\">17,18</a>]. Patients with ALL are generally acutely ill. (See <a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-precursor-b-cell-acute-lymphoblastic-leukemia-lymphoma\" class=\"medical medical_review\">&quot;Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Solid tumors</strong> &ndash; Nonhematologic cancers can cause eosinophilia, most notably adenocarcinomas of the gastrointestinal tract (eg, stomach, large bowel), lung, and squamous epithelium (eg, cervix, vagina, penis, skin, nasopharynx, bladder).</p><p/><p class=\"headingAnchor\" id=\"H199340137\"><span class=\"h3\">Parasites and other infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Parasitic helminths (worms) are the most commonly identified infectious cause of eosinophilia [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/19\" class=\"abstract_t\">19</a>]. Helminths that can elicit eosinophilia are listed in the tables (<a href=\"image.htm?imageKey=ID%2F82384\" class=\"graphic graphic_table graphicRef82384 \">table 3</a> and <a href=\"image.htm?imageKey=ID%2F59981\" class=\"graphic graphic_table graphicRef59981 \">table 4</a> and <a href=\"image.htm?imageKey=ID%2F84014\" class=\"graphic graphic_table graphicRef84014 \">table 5</a>).</p><p>Some parasitic infections are associated only with specific geographical exposures. However, many parasites are endemic worldwide. Eosinophilia may increase transiently with therapy, with the magnitude of post-treatment eosinophilia dependent on the parasite burden and host responses [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/20,21\" class=\"abstract_t\">20,21</a>]. Resolution of eosinophilia following treatment of a helminthic infection may take months, possibly because killed helminths in the tissue may act as an ongoing source of antigens.</p><p class=\"headingAnchor\" id=\"H199340240\"><span class=\"h4\">Parasites to consider in all patients</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Some parasites are endemic worldwide and should be considered in all patients with eosinophilia, regardless of where the individual has resided or traveled. All of these parasites may cause symptomatic or asymptomatic infection:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Strongyloidiasis</strong> &ndash; <em>Strongyloides stercoralis</em> is endemic worldwide in areas with a hot, humid climate (eg, the southeastern United States and southern Europe) and can directly penetrate the skin upon contact with soil or water contaminated with human feces. Strongyloidiasis can have a latency of years between the initial exposure and the development of symptoms, and infection easily could be overlooked if the patient or clinician were unaware of the possibility of remote exposure. (See <a href=\"topic.htm?path=strongyloidiasis\" class=\"medical medical_review\">&quot;Strongyloidiasis&quot;</a>.)</p><p/><p class=\"bulletIndent1\">We perform <em>Strongyloides</em> serology as part of the initial evaluation in all patients with a potential exposure history. <em>Strongyloides</em> is of greatest concern for several reasons:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>The parasite can internally reinfect, enabling ongoing infections even decades after initial exposure.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Eosinophilia of varying levels may be the only indication of a subclinical infection.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Disseminated hyperinfection can develop in patients given systemic glucocorticoids. Thus, latent infection with this parasite must be excluded or the patient empirically treated prior to the initiation of systemic glucocorticoid therapy. (See <a href=\"topic.htm?path=hypereosinophilic-syndromes-treatment\" class=\"medical medical_review\">&quot;Hypereosinophilic syndromes: Treatment&quot;</a> and <a href=\"topic.htm?path=hypereosinophilic-syndromes-treatment#H17\" class=\"medical medical_review\">&quot;Hypereosinophilic syndromes: Treatment&quot;, section on 'Glucocorticoids'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Toxocariasis</strong> &ndash; <em>Toxocara canis</em> and <em>cati</em> are endemic worldwide and can be ingested with soil or food contaminated by dog or cat feces. This is typically a concern with children who may ingest contaminated soil. Affected individuals are acutely ill. Testing by serology may be appropriate in children. (See <a href=\"topic.htm?path=toxocariasis-visceral-and-ocular-larva-migrans\" class=\"medical medical_review\">&quot;Toxocariasis: Visceral and ocular larva migrans&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Trichinellosis</strong> &ndash; <em>Trichinella</em> species have been reported worldwide. Human infections are seen most commonly in China, Thailand, Mexico, Argentina, Bolivia, and parts of Eastern and Central Europe. Infection results from ingestion of undercooked meat, especially pork. Testing by serology may be appropriate in individuals with potential exposure. (See <a href=\"topic.htm?path=trichinellosis\" class=\"medical medical_review\">&quot;Trichinellosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hookworm</strong> &ndash; <em>Ancylostoma duodenale</em> is found in Mediterranean countries, Iran, India, Pakistan, and Asia. <em>Necator americanus</em> lives in North America, South America, Central Africa, Indonesia, the South Pacific, and parts of India. These worms infect humans by larval penetration into skin. Affected individuals may have rash, cough, and gastrointestinal symptoms. Testing by stool studies is indicated in individuals with an appropriate exposure history. (See <a href=\"topic.htm?path=hookworm-infection\" class=\"medical medical_review\">&quot;Hookworm infection&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H199340318\"><span class=\"h4\">Infections relevant to certain geographic areas</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In contrast to parasites endemic worldwide, other parasitic infections associated with eosinophilia are more geographically limited (see <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia#H7345421\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;, section on 'Travel'</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Filariasis</strong> &ndash; Filarial infections of humans can affect many different organs, including the skin, lymphatics, lungs, and eyes. Transmission is via arthropod vectors (eg, mosquitoes, blackflies). Most filarial infections are endemic only in the tropics and subtropics, with the exception of zoonotic filariae (<em>Dirofilaria</em> and <em>Mansonella</em> species), which cause self-limited infections in humans that are rarely associated with peripheral blood eosinophilia. (See <a href=\"topic.htm?path=lymphatic-filariasis-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=tropical-pulmonary-eosinophilia\" class=\"medical medical_review\">&quot;Tropical pulmonary eosinophilia&quot;</a> and <a href=\"topic.htm?path=mansonella-infections\" class=\"medical medical_review\">&quot;Mansonella infections&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Schistosomiasis</strong> &ndash; Schistosome species are endemic in some regions of the tropics and Africa. Most patients are asymptomatic; however, acute symptoms localized to specific organs (eg, swimmer's itch, Katayama fever) or generalized fatigue may occur. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, and clinical manifestations of schistosomiasis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H199340385\"><span class=\"h4\">Nonhelminthic infections</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nonhelminthic parasites and other infections are occasionally associated with eosinophilia:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ectoparasites (eg, scabies mites) can cause eosinophilia, especially if the infection is severe or there is an underlying immunodeficiency or skin disorder [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/22,23\" class=\"abstract_t\">22,23</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Some fungi can also cause eosinophilia. <em>Aspergillus</em> is the one most commonly implicated in the setting of allergic bronchopulmonary aspergillosis (ABPA). Coccidioidomycosis has also been associated with eosinophilia in approximately 25 percent of patients, with eosinophilia peaking during the second or third week of illness or during disseminated infection [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/24-26\" class=\"abstract_t\">24-26</a>]. Basidiobolomycosis, paracoccidioidomycosis, disseminated histoplasmosis, and cryptococcosis also have been associated with eosinophilia. (See <a href=\"topic.htm?path=primary-coccidioidal-infection#H6\" class=\"medical medical_review\">&quot;Primary coccidioidal infection&quot;, section on 'Clinical manifestations'</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-allergic-bronchopulmonary-aspergillosis#H1150172384\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis&quot;, section on 'Differential diagnosis'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Retroviral infections can sometimes be accompanied by eosinophilia. Infection with the human T-lymphotropic virus HTLV-II is commonly associated with eosinophilia; HTLV-I infection may also be implicated [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/27,28\" class=\"abstract_t\">27,28</a>]. Eosinophilia also may occur with human immunodeficiency virus (HIV)-1 infection, but in the setting of HIV infection, the eosinophilia is usually due to an associated condition (eg, drug reaction, adrenal insufficiency, eosinophilic folliculitis) rather than a direct result of the HIV virus. (See <a href=\"topic.htm?path=pituitary-and-adrenal-gland-dysfunction-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Pituitary and adrenal gland dysfunction in HIV-infected patients&quot;</a> and <a href=\"topic.htm?path=hiv-associated-eosinophilic-folliculitis\" class=\"medical medical_review\">&quot;HIV-associated eosinophilic folliculitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Protozoal parasites (eg, <em>Giardia</em>, malaria, <em>Babesia</em>) generally do not produce eosinophilia. Exceptions are the intestinal protozoa <em>Isospora belli</em>, <em>Dientamoeba fragilis</em>, and <em>Sarcocystis </em>species, which can cause peripheral eosinophilia. <em>Sarcocystis</em> can also cause eosinophilic myositis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/29\" class=\"abstract_t\">29</a>]. (See <a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia#H7345421\" class=\"medical medical_review\">&quot;Approach to the patient with unexplained eosinophilia&quot;, section on 'Travel'</a>.)</p><p/><p>Eosinophilia in a patient with fever is <strong>unlikely</strong> to be due to a bacterial or viral infection, since most acute bacterial or viral infections are associated with <strong>decreased</strong> eosinophil counts. High quality evidence is lacking for an association of eosinophilia with tuberculosis, toxoplasma, bartonellosis, or group A streptococcal infections.</p><p class=\"headingAnchor\" id=\"H199340657\"><span class=\"h3\">Allergic disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of allergic disorders are associated with eosinophilia. In general, these disorders cause mild eosinophilia. Thus, the presence of severe eosinophilia (ie, eosinophils <span class=\"nowrap\">&gt;5000/microL)</span> and sometimes moderate eosinophilia (1500 to <span class=\"nowrap\">5000/microL)</span> should prompt a more extensive evaluation.</p><p class=\"headingAnchor\" id=\"H347120666\"><span class=\"h4\">Organ-specific allergic disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There is significant overlap between the different categorization systems of disorders causing eosinophilia. Several allergic disorders predominantly affect one organ system, including allergic rhinitis, chronic rhinosinusitis, asthma, and atopic dermatitis. Some eosinophilic gastrointestinal disorders appear to have a significant allergic component. These are discussed below. (See <a href=\"#H261622134\" class=\"local\">'Disorders with eosinophilic involvement of specific organs'</a> below.)</p><p class=\"headingAnchor\" id=\"H347120672\"><span class=\"h4\">Drug reactions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of drug reactions are associated with peripheral blood eosinophilia; some drugs are more commonly associated with specific syndromes (<a href=\"image.htm?imageKey=ID%2F84015\" class=\"graphic graphic_table graphicRef84015 \">table 6</a>). Associated clinical findings may be helpful in identifying an implicated drug. A temporal relationship between drug initiation and development of eosinophilia should be determined, if possible. However, the latency between exposure and eosinophilia can range from days to years.</p><p>Drug reaction with eosinophilia and systemic symptoms (DRESS) is a potentially life-threatening systemic hypersensitivity reaction. The latency period between drug exposure and development of symptoms may be relatively long (eg, two to six weeks). Fever, malaise, lymphadenopathy, and skin eruption are the most common initial symptoms, but they are not invariably present. The morbilliform eruption can become confluent and progress to exfoliative dermatitis in some patients (<a href=\"image.htm?imageKey=DERM%2F86763\" class=\"graphic graphic_picture graphicRef86763 \">picture 2</a> and <a href=\"image.htm?imageKey=DERM%2F86859\" class=\"graphic graphic_picture graphicRef86859 \">picture 3</a> and <a href=\"image.htm?imageKey=DERM%2F86860\" class=\"graphic graphic_picture graphicRef86860 \">picture 4</a>). Additional systemic symptoms may be related to visceral involvement of liver, kidneys, lungs, or other organs. Hematologic abnormalities include leukocytosis with eosinophilia <span class=\"nowrap\">and/or</span> atypical lymphocytosis. Symptoms can persist for up to several years following discontinuation of the implicated drug. (See <a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress\" class=\"medical medical_review\">&quot;Drug reaction with eosinophilia and systemic symptoms (DRESS)&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H199340932\"><span class=\"h3\">Adrenal insufficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Adrenal insufficiency has been associated with eosinophilia, especially in acutely ill patients. This is believed to be due to loss of endogenous glucocorticoids. Severe adrenal insufficiency presenting as isolated eosinophilia in an otherwise healthy individual is rare. In contrast, eosinophilia may be a marker of adrenal insufficiency in some high-risk settings (eg, tuberculosis, opportunistic infections in a patient with HIV infection, tapering or discontinuation of glucocorticoids, acute adrenal hemorrhage, necrosis, or infarction). In these settings, eosinophilia does not typically cause end-organ damage. In these rare cases, we obtain a cortisol level <span class=\"nowrap\">and/or</span> <a href=\"topic.htm?path=cosyntropin-tetracosactide-drug-information\" class=\"drug drug_general\">ACTH stimulation test</a>. (See <a href=\"topic.htm?path=clinical-manifestations-of-adrenal-insufficiency-in-adults\" class=\"medical medical_review\">&quot;Clinical manifestations of adrenal insufficiency in adults&quot;</a> and <a href=\"topic.htm?path=diagnosis-of-adrenal-insufficiency-in-adults\" class=\"medical medical_review\">&quot;Diagnosis of adrenal insufficiency in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H199340960\"><span class=\"h3\">Connective tissue/rheumatologic diseases</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Eosinophilia may be found in the following connective tissue diseases:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic granulomatosis with polyangiitis </strong>&ndash; Eosinophilic granulomatosis with polyangiitis (EGPA, previously called Churg-Strauss syndrome) is the major vasculitis syndrome associated with eosinophilia. Patients typically present with asthma and other lung and upper airway findings; vasculitic symptoms typically develop years later. Moderate to severe peripheral blood eosinophilia is common although use of steroids may suppress eosinophil production. (See <a href=\"topic.htm?path=epidemiology-pathogenesis-and-pathology-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, and pathology of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Toxin-induced syndromes</strong> &ndash; Syndromes caused by toxic ingestions include the <strong>eosinophilia-myalgia syndrome</strong>, attributed to ingestion of a contaminated preparation of L-tryptophan, and <strong>toxic oil syndrome</strong>, caused by ingestion of edible oil adulterated with denatured rapeseed oil. Both of these entities are chronic, persistent, multisystem diseases. Few new cases have been reported since the offending agents were recognized. (See <a href=\"topic.htm?path=risk-factors-for-and-possible-causes-of-systemic-sclerosis-scleroderma#H14\" class=\"medical medical_review\">&quot;Risk factors for and possible causes of systemic sclerosis (scleroderma)&quot;, section on 'L-tryptophan'</a> and <a href=\"topic.htm?path=risk-factors-for-and-possible-causes-of-systemic-sclerosis-scleroderma#H13\" class=\"medical medical_review\">&quot;Risk factors for and possible causes of systemic sclerosis (scleroderma)&quot;, section on 'Contaminated rapeseed oil'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other connective tissue disorders</strong> &ndash; Less commonly, eosinophilia may accompany other connective tissue disorders, including the following:</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Dermatomyositis</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Severe rheumatoid arthritis </p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Progressive systemic sclerosis</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Sj&ouml;gren's syndrome </p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Thromboangiitis obliterans with eosinophilia of the temporal arteries</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Granulomatosis with polyangiitis (Wegener's syndrome)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Systemic lupus erythematosus</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Beh&ccedil;et syndrome</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>IgG4-related disease</p><p/><p class=\"bulletIndent1\">These conditions are discussed in separate topic reviews.</p><p/><p class=\"headingAnchor\" id=\"H199341010\"><span class=\"h3\">Other rare causes</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Other rare causes include cholesterol embolization, autoimmune lymphoproliferative syndrome (ALPS), and several primary or secondary forms of immunodeficiency.</p><p>Cholesterol embolization may occasionally manifest as isolated blood eosinophilia. More typically, there are other suggestive findings (eg, livido reticularis, purple toes, renal insufficiency) and hematologic changes (eg, increased erythrocyte sedimentation rate, hypocomplementemia, thrombocytopenia) [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/30\" class=\"abstract_t\">30</a>]. (See <a href=\"topic.htm?path=embolism-from-atherosclerotic-plaque-atheroembolism-cholesterol-crystal-embolism\" class=\"medical medical_review\">&quot;Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)&quot;</a>.)</p><p>ALPS is a hereditary disorder characterized by immune dysregulation and lymphoproliferation. Asymptomatic eosinophilia occurs in approximately 10 percent of patients with ALPS and is associated with poor outcome [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/31\" class=\"abstract_t\">31</a>]. (See <a href=\"topic.htm?path=autoimmune-lymphoproliferative-syndrome-alps-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis&quot;</a> and <a href=\"topic.htm?path=autoimmune-lymphoproliferative-syndrome-alps-clinical-features-and-diagnosis\" class=\"medical medical_review\">&quot;Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis&quot;</a>.)</p><p>Some primary immunodeficiency syndromes are associated with eosinophilia, including:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperimmunoglobulin E syndrome (also called Job syndrome, due to STAT3 or DOCK8 deficiency), which is characterized by chronic dermatitis, recurrent bacterial infections, and elevated serum immunoglobulin E (IgE). Hyperimmunoglobulin E syndrome is most often diagnosed in older children or adults with staphylococcal pneumonias or recurrent abscesses and chronic eczema. (See <a href=\"topic.htm?path=autosomal-dominant-hyperimmunoglobulin-e-syndrome\" class=\"medical medical_review\">&quot;Autosomal dominant hyperimmunoglobulin E syndrome&quot;</a> and <a href=\"topic.htm?path=combined-immunodeficiencies#H31\" class=\"medical medical_review\">&quot;Combined immunodeficiencies&quot;, section on 'Dedicator of cytokinesis 8 deficiency'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Omenn syndrome, a form of severe combined immunodeficiency (SCID) characterized by exudative rash, lymphadenopathy, hepatosplenomegaly, eosinophilia, elevated serum IgE, chronic diarrhea, and failure to thrive. Children usually present before three months of age.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>IPEX, a rare X-linked immune dysregulatory disorder involving the transcription factor FOXP3 that typically presents during infancy with a triad of enteropathy, autoimmune endocrinopathy, and dermatitis. (See <a href=\"topic.htm?path=ipex-immune-dysregulation-polyendocrinopathy-enteropathy-x-linked\" class=\"medical medical_review\">&quot;IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>ZAP-70 deficiency, which usually presents within the first two years of life with recurrent infections and sometimes also chronic diarrhea <span class=\"nowrap\">and/or</span> failure to thrive, similar to SCID. Some patients have eosinophilia [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/32\" class=\"abstract_t\">32</a>]. (See <a href=\"topic.htm?path=zap-70-deficiency\" class=\"medical medical_review\">&quot;ZAP-70 deficiency&quot;</a>.)</p><p/><p>Acquired forms of immunodeficiency <span class=\"nowrap\">and/or</span> inflammation may also be associated with eosinophilia, including the following [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/33\" class=\"abstract_t\">33</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Graft-versus-host disease following hematopoietic cell transplantation</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inflammatory bowel disease</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sarcoidosis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bullous pemphigoid</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dermatitis herpetiformis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rejection of a transplanted solid organ</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Irritation of serosal surfaces (mechanical, chemical, or radiation-induced)</p><p/><p class=\"headingAnchor\" id=\"H261622134\"><span class=\"h1\">DISORDERS WITH EOSINOPHILIC INVOLVEMENT OF SPECIFIC ORGANS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In the disorders listed in this section, involvement of specific tissues or organ systems may bring the patient to medical attention. Biopsy then reveals eosinophilic infiltration, allowing for a more focused diagnostic work-up. <strong>Accompanying blood eosinophilia is variable</strong>, since tissue eosinophilia can occur with or without eosinophilia in the peripheral blood.</p><p class=\"headingAnchor\" id=\"H261623233\"><span class=\"h2\">Dermatologic</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Eosinophils participate in the inflammatory infiltrate in numerous dermatologic conditions.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Atopic dermatitis</strong> &ndash; Atopic dermatitis (ie, eczema) is a chronic inflammatory skin condition due to impaired epidermal barrier function <span class=\"nowrap\">and/or</span> immune dysfunction that may be accompanied by blood and tissue eosinophilia. However, eosinophil counts <span class=\"nowrap\">&gt;1500/microL</span> are relatively infrequent in this disorder. Marked eosinophilia, dramatic elevation of serum immunoglobulin E (IgE), recurrent infections, or other atypical features should prompt evaluation for other causes of eosinophilia. (See <a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic panniculitis</strong> &ndash; Eosinophilic panniculitis is characterized by a prominent eosinophil infiltration of subcutaneous fat [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/34\" class=\"abstract_t\">34</a>]. Lesions often are nodular but may present as plaques or vesicles. This pathology is commonly associated with gnathostomiasis, leukocytoclastic vasculitis, and erythema nodosum [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/34-36\" class=\"abstract_t\">34-36</a>]. Eosinophilic panniculitis can also develop in response to injected medications [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/37-39\" class=\"abstract_t\">37-39</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Episodic angioedema with eosinophilia</strong> &ndash; Although blood eosinophilia does not usually accompany angioedema, the entity of episodic angioedema with eosinophilia (Gleich syndrome) is characterized by recurrent episodes of angioedema, urticaria, pruritus, fever, weight gain, elevated serum immunoglobulin M (IgM), and leukocytosis with marked blood eosinophilia. (See <a href=\"topic.htm?path=hypereosinophilic-syndromes-clinical-manifestations-pathophysiology-and-diagnosis#H4769463\" class=\"medical medical_review\">&quot;Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis&quot;, section on 'Episodic angioedema with eosinophilia (Gleich syndrome)'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Kimura disease and angiolymphoid hyperplasia with eosinophilia</strong> &ndash; Kimura disease presents as large subcutaneous masses on the head or neck of East Asian males, whereas angiolymphoid hyperplasia with eosinophilia (also known as epithelioid hemangioma) occurs in all races and is characterized by generally smaller and more superficial lesions. Eosinophilia is common to both conditions, which are of unknown origin [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/40-42\" class=\"abstract_t\">40-42</a>]. One report described a series of 21 cases of Kimura disease in the United States, the majority of which had eosinophilia [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/42\" class=\"abstract_t\">42</a>]. The posterior auricular or cervical lymph nodes were most often involved. Consistent histologic features included follicular hyperplasia, eosinophilic infiltrates, and proliferation of postcapillary venules. Treatment usually consists of surgical resection. In addition, some case reports suggest a beneficial effect from glucocorticoids [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/43\" class=\"abstract_t\">43</a>], the selective H1 receptor antagonist <a href=\"topic.htm?path=cetirizine-drug-information\" class=\"drug drug_general\">cetirizine</a> [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/44\" class=\"abstract_t\">44</a>], radiotherapy [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/45,46\" class=\"abstract_t\">45,46</a>], topical <a href=\"topic.htm?path=tacrolimus-drug-information\" class=\"drug drug_general\">tacrolimus</a> [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/47\" class=\"abstract_t\">47</a>], and <a href=\"topic.htm?path=thalidomide-drug-information\" class=\"drug drug_general\">thalidomide</a> [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/48\" class=\"abstract_t\">48</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic fasciitis </strong>&ndash; Eosinophilic fasciitis, also known as Shulman's syndrome, is characterized by symmetrical induration of the skin. The onset is typically acute, and findings include erythema, swelling, and induration of the extremities that is accompanied by eosinophilia in up to two-thirds of patients. A subacute course may also occur. The thickening and hide-bound quality of the affected skin is somewhat similar to that seen with the scleroderma-spectrum disorders. However, the irregular, woody, peau d'orange texture of eosinophilic fasciitis is distinct from the smooth, shiny skin surface seen in patients with systemic sclerosis or localized scleroderma (<a href=\"image.htm?imageKey=RHEUM%2F65829\" class=\"graphic graphic_picture graphicRef65829 \">picture 5</a>). Skin involvement most commonly occurs on the extremities, neck, and trunk. (See <a href=\"topic.htm?path=eosinophilic-fasciitis\" class=\"medical medical_review\">&quot;Eosinophilic fasciitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic cellulitis</strong> &ndash; Eosinophilic cellulitis, also known as Wells syndrome, is marked by recurrent lesions on the extremities; blood eosinophilia is present in 50 percent of cases (<a href=\"image.htm?imageKey=HEME%2F87394\" class=\"graphic graphic_picture graphicRef87394 \">picture 6</a>) [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/49,50\" class=\"abstract_t\">49,50</a>]. There are several different clinical variants [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/50\" class=\"abstract_t\">50</a>]. Involved skin appears cellulitic but is not tender or warm; the diagnosis may be suspected when patients do not respond to appropriate antibiotic treatment for bacterial cellulitis. Histology of a lesion in the acute stage shows edematous dermis infiltrated by eosinophils in a perivascular pattern. In the chronic stage, distinctive &quot;flame figures&quot; composed of masses of collagen and intact and degranulated eosinophils may be seen [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/51\" class=\"abstract_t\">51</a>]. The skin findings usually resolve in two to eight weeks. Wells syndrome may be idiopathic, drug-related, or associated with myeloproliferative, immunologic, or infectious disorders [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/52-54\" class=\"abstract_t\">52-54</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic pustular folliculitis</strong> &ndash; Human immunodeficiency virus (HIV)-associated eosinophilic pustular folliculitis is characterized by recurrent, pruritic crops of discrete, erythematous, urticarial follicular papules and rare pustules, with a diameter of 3 to 5 mm (<a href=\"image.htm?imageKey=DERM%2F87125\" class=\"graphic graphic_picture graphicRef87125 \">picture 7</a> and <a href=\"image.htm?imageKey=DERM%2F54404\" class=\"graphic graphic_picture graphicRef54404 \">picture 8</a>). The most common areas of involvement are the scalp, face, neck, and upper trunk; all are areas with a high concentration of sebaceous glands. It is found primarily in HIV-positive patients, patients undergoing treatment for hematologic malignancies and bone marrow transplant recipients [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/55\" class=\"abstract_t\">55</a>]. However, it can also be seen in infants in a self-limited form [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/56\" class=\"abstract_t\">56</a>]. (See <a href=\"topic.htm?path=hiv-associated-eosinophilic-folliculitis\" class=\"medical medical_review\">&quot;HIV-associated eosinophilic folliculitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Recurrent cutaneous necrotizing eosinophilic vasculitis </strong>&ndash; In this distinct vasculitis of small dermal vessels, skin biopsies show necrotizing vasculitis with minimal or absent leukocytoclasis and an almost exclusive eosinophilic infiltration in vessel walls and lumen [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/57-59\" class=\"abstract_t\">57-59</a>]. Patients usually respond to systemic glucocorticoid treatment and pursue a chronic but relatively benign course.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic ulcer of the oral mucosa </strong>&ndash; These ulcerated lesions appear to result from trauma, are usually tender and multiple, and often involve the tongue. Eosinophilic infiltration is prominent, and the lesions usually heal spontaneously over several weeks [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/60-63\" class=\"abstract_t\">60-63</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other dermatologic conditions</strong> &ndash; Tissue eosinophilia may be seen in blistering diseases such as bullous pemphigoid, pemphigus vulgaris, dermatitis herpetiformis, and herpes gestationis. Eosinophils or deposited eosinophil granule proteins can also be prominent in drug-induced lesions, chronic urticaria, solar urticaria, delayed pressure urticaria [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/64\" class=\"abstract_t\">64</a>], the pregnancy-related dermatosis pruritic urticarial papules and plaques syndrome (PUPPS), and in orbital pseudotumors [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/65\" class=\"abstract_t\">65</a>]. An uncommon disorder, characterized by the association of nodules, eosinophilia, rheumatism, dermatitis, and swelling (NERDS), includes prominent para-articular nodules, recurrent urticaria with angioedema, and tissue and blood eosinophilia [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/66\" class=\"abstract_t\">66</a>].</p><p/><p class=\"headingAnchor\" id=\"H261623754\"><span class=\"h2\">Sinonasal and pulmonary</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A variety of pulmonary diseases can be associated with eosinophilic inflammation of the airways and pleura. These are described briefly here and reviewed in detail elsewhere. (See <a href=\"topic.htm?path=causes-of-pulmonary-eosinophilia\" class=\"medical medical_review\">&quot;Causes of pulmonary eosinophilia&quot;</a> and <a href=\"topic.htm?path=tropical-pulmonary-eosinophilia\" class=\"medical medical_review\">&quot;Tropical pulmonary eosinophilia&quot;</a> and <a href=\"topic.htm?path=pleural-fluid-eosinophilia\" class=\"medical medical_review\">&quot;Pleural fluid eosinophilia&quot;</a> and <a href=\"topic.htm?path=chronic-eosinophilic-pneumonia\" class=\"medical medical_review\">&quot;Chronic eosinophilic pneumonia&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Allergic rhinitis</strong> &ndash; Allergic rhinitis is a common disorder that presents with sneezing, rhinorrhea, and nasal congestion. If present, blood eosinophilia is usually mild to moderate. (See <a href=\"topic.htm?path=allergic-rhinitis-clinical-manifestations-epidemiology-and-diagnosis#H7950282\" class=\"medical medical_review\">&quot;Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis&quot;, section on 'Routine laboratory findings'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chronic rhinosinusitis</strong> &ndash; Eosinophilia of involved tissues is frequent in several forms of chronic rhinosinusitis. Specific disorders that may be accompanied by blood and tissue eosinophilia include allergic fungal rhinosinusitis, chronic rhinosinusitis with nasal polyposis, often associated with <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> sensitivity, and the sinusitis of eosinophilic granulomatosis with polyangiitis ([EGPA] previously called Churg-Strauss syndrome). (See <a href=\"topic.htm?path=allergic-fungal-rhinosinusitis\" class=\"medical medical_review\">&quot;Allergic fungal rhinosinusitis&quot;</a> and <a href=\"topic.htm?path=chronic-rhinosinusitis-clinical-manifestations-pathophysiology-and-diagnosis#H4\" class=\"medical medical_review\">&quot;Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis&quot;, section on 'CRS with nasal polyposis'</a> and <a href=\"topic.htm?path=aspirin-exacerbated-respiratory-disease\" class=\"medical medical_review\">&quot;Aspirin-exacerbated respiratory disease&quot;</a> and <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Asthma</strong> &ndash; Asthma can cause eosinophilia, and other causes of eosinophilia (eg, helminthic infection, fungal infection) can present with bronchospasm mimicking asthma. Thus, it is helpful to establish the temporal relationship between development of asthma symptoms and eosinophilia, if possible. Helminthic infections that can cause wheezing are reviewed separately. (See <a href=\"topic.htm?path=causes-of-pulmonary-eosinophilia#H3\" class=\"medical medical_review\">&quot;Causes of pulmonary eosinophilia&quot;, section on 'Transpulmonary passage of helminth larvae (L&ouml;ffler syndrome)'</a>.)</p><p/><p class=\"bulletIndent1\">Asthma-associated eosinophilia is usually mild to moderate (eg, <span class=\"nowrap\">&lt;1500/microL)</span> [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/67\" class=\"abstract_t\">67</a>]. Therefore, eosinophilia <span class=\"nowrap\">&ge;1500/microL</span> should prompt consideration of other eosinophilic pulmonary conditions (eg, allergic bronchopulmonary aspergillosis [ABPA], EGPA, nasal polyposis). (See <a href=\"topic.htm?path=evaluation-of-severe-asthma-in-adolescents-and-adults\" class=\"medical medical_review\">&quot;Evaluation of severe asthma in adolescents and adults&quot;</a> and <a href=\"topic.htm?path=evaluation-of-wheezing-illnesses-other-than-asthma-in-adults\" class=\"medical medical_review\">&quot;Evaluation of wheezing illnesses other than asthma in adults&quot;</a> and <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other</strong> <strong>pulmonary diseases</strong> &ndash; Abnormally high numbers of eosinophils may be seen in the pulmonary parenchyma in many conditions. These include parasitic infections, drug reactions, asthma, allergic bronchopulmonary aspergillosis, acute and chronic eosinophilic pneumonias, the hypereosinophilic syndrome, and EGPA.</p><p/><p class=\"bulletIndent1\">Less commonly, pulmonary eosinophilia occurs in association with bronchiolitis obliterans organizing pneumonia, rheumatoid arthritis, Sj&ouml;gren's syndrome, sarcoidosis, malignancy, eosinophilic granuloma, post-radiation therapy, graft-versus-host disease, and systemic sclerosis. Coccidioidal infection is in the differential diagnosis of eosinophilic pneumonia because organisms may be absent from cultures and open lung biopsy specimens. (See <a href=\"topic.htm?path=causes-of-pulmonary-eosinophilia\" class=\"medical medical_review\">&quot;Causes of pulmonary eosinophilia&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pleural diseases</strong> &ndash; Pleural fluid eosinophilia is commonly associated with air or blood in the pleural space and usually has a benign, self-limited course. (See <a href=\"topic.htm?path=pleural-fluid-eosinophilia\" class=\"medical medical_review\">&quot;Pleural fluid eosinophilia&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H261623906\"><span class=\"h2\">Gastrointestinal and hepatobiliary</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Tissue eosinophilia develops with a number of gastrointestinal and hepatobiliary disorders, and symptoms are related to eosinophil infiltration. Blood eosinophilia is present less frequently. Gastrointestinal eosinophilia elicited by intestinal parasites or by a hypersensitivity reaction to medications must be excluded in patients with the following eosinophilic conditions.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic esophagitis</strong> &ndash; Eosinophilic esophagitis is a disorder associated with esophageal eosinophilia. Adults typically present with dysphagia <span class=\"nowrap\">and/or</span> food impaction while children have a more variable presentation depending in part upon their age. Patients often have a history of allergies, and laboratories may demonstrate a peripheral eosinophilia. Strictures may be seen on endoscopy; histopathology reveals mucosal infiltration with eosinophils. Blood eosinophilia may or may not be present. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-eosinophilic-esophagitis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of eosinophilic esophagitis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic gastroenteritis</strong> &ndash; Eosinophilic gastroenteritis is an uncommon disorder characterized by gastrointestinal symptoms, blood eosinophilia, and eosinophilic infiltration of the gastrointestinal wall; peak onset is in the third decade of life. Although allergies to foods contribute to this disease in some children, allergic etiologies are not common in adults. This disorder is reviewed in detail separately. (See <a href=\"topic.htm?path=eosinophilic-gastroenteritis\" class=\"medical medical_review\">&quot;Eosinophilic gastroenteritis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other disorders</strong> &ndash; Local tissue infiltration may be noted in patients with gastroesophageal acid reflux disease [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/68,69\" class=\"abstract_t\">68,69</a>], <em>Helicobacter pylori</em> infection [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/70\" class=\"abstract_t\">70</a>], inflammatory bowel disease [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/71\" class=\"abstract_t\">71</a>], celiac disease, and collagenous colitis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/72\" class=\"abstract_t\">72</a>]. Patients with inflammatory bowel disease and celiac disease may also have peripheral blood eosinophilia.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hepatobiliary diseases</strong> &ndash; Hepatic eosinophilia develops in response to some medications such as semisynthetic penicillins and tetracyclines. Hepatitis is also a feature of DRESS. (See <a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress\" class=\"medical medical_review\">&quot;Drug reaction with eosinophilia and systemic symptoms (DRESS)&quot;</a>.)</p><p/><p class=\"bulletIndent1\">Helminthic parasites that affect the liver include Schistosomes (whose eggs embolize into the portal system and elicit eosinophil-enriched granulomas and fibrosis), migrating larvae (eg, visceral larva migrans), and hepatobiliary parasites (eg, <em>Clonorchis</em>). (See <a href=\"#H199340137\" class=\"local\">'Parasites and other infections'</a> above.)</p><p/><p class=\"bulletIndent1\">Other disorders that may present with hepatic disease include primary biliary cirrhosis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/73\" class=\"abstract_t\">73</a>], hypereosinophilic syndrome [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/74,75\" class=\"abstract_t\">74,75</a>], sclerosing cholangitis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/76\" class=\"abstract_t\">76</a>], eosinophilic cholangitis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/77\" class=\"abstract_t\">77</a>], and eosinophilic cholecystitis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/78\" class=\"abstract_t\">78</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Transplant rejection</strong> &ndash; Following liver transplant, eosinophilic infiltrate of the portal tract on biopsy may be a warning sign of rejection. (See <a href=\"topic.htm?path=liver-transplantation-diagnosis-of-acute-cellular-rejection#H4\" class=\"medical medical_review\">&quot;Liver transplantation: Diagnosis of acute cellular rejection&quot;, section on 'Liver biopsy'</a>.)</p><p/><p class=\"headingAnchor\" id=\"H261624150\"><span class=\"h2\">Cardiac</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Endomyocardial fibrosis and intraventricular thrombosis may occur following a variety of eosinophilic syndromes including hypersensitivity myocarditis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/79\" class=\"abstract_t\">79</a>], parasitic infections [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/74,80\" class=\"abstract_t\">74,80</a>], hypereosinophilic syndrome [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/74,80\" class=\"abstract_t\">74,80</a>], eosinophilic leukemia, sarcomas, carcinomas, lymphomas [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/81\" class=\"abstract_t\">81</a>], granulocyte-macrophage colony-stimulating factor (GM-CSF) administration [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/82\" class=\"abstract_t\">82</a>], and prolonged drug-induced eosinophilia. (See <a href=\"topic.htm?path=etiology-and-pathogenesis-of-myocarditis#H8\" class=\"medical medical_review\">&quot;Etiology and pathogenesis of myocarditis&quot;, section on 'Hypersensitivity myocarditis'</a> and <a href=\"topic.htm?path=hypereosinophilic-syndromes-clinical-manifestations-pathophysiology-and-diagnosis#H15\" class=\"medical medical_review\">&quot;Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis&quot;, section on 'Cardiac disease'</a>.)</p><p>Eosinophilic coronary arteritis, usually limited to the small vessels, may be seen in EGPA. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss#H7\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)&quot;, section on 'Cardiovascular'</a>.)</p><p class=\"headingAnchor\" id=\"H261624250\"><span class=\"h2\">Renal</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of conditions can result either in eosinophiluria or eosinophilic infiltration of the kidneys or urinary tract. Eosinophiluria may be found in patients with drug-induced acute interstitial nephritis, rapidly progressive and acute poststreptococcal glomerulonephritis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/83\" class=\"abstract_t\">83</a>], eosinophilic prostatitis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/84\" class=\"abstract_t\">84</a>], eosinophilic cystitis, renal transplant rejection, bladder cancer [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/85\" class=\"abstract_t\">85</a>], cholesterol embolization, and schistosomiasis [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/86,87\" class=\"abstract_t\">86,87</a>]. (See <a href=\"topic.htm?path=the-significance-of-urinary-eosinophils\" class=\"medical medical_review\">&quot;The significance of urinary eosinophils&quot;</a>.)</p><p>Eosinophilic infiltration of the kidneys or urinary tract may be seen with the following disorders:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Drug-induced acute interstitial nephritis</strong> &ndash; Acute interstitial nephritis (AIN) is a renal condition that causes a decline in creatinine clearance and is characterized by an inflammatory infiltrate in the kidney interstitium. Drugs are the most common cause of AIN. Implicated drugs include nonsteroidal anti-inflammatory drugs ([NSAIDs] including selective cyclooxygenase [COX]-2 inhibitors), penicillins and cephalosporins, <a href=\"topic.htm?path=rifampin-rifampicin-drug-information\" class=\"drug drug_general\">rifampin</a>, antimicrobial sulfonamides, <a href=\"topic.htm?path=ciprofloxacin-drug-information\" class=\"drug drug_general\">ciprofloxacin</a> and other quinolones, diuretics, <a href=\"topic.htm?path=cimetidine-drug-information\" class=\"drug drug_general\">cimetidine</a>, <a href=\"topic.htm?path=allopurinol-drug-information\" class=\"drug drug_general\">allopurinol</a>, proton pump inhibitors, <a href=\"topic.htm?path=indinavir-drug-information\" class=\"drug drug_general\">indinavir</a>, and 5-aminosalicylates. Patients generally present with a rise in the plasma creatinine concentration, which (if drug induced) is temporally related to administration of the offending drug. They may have fever, rash, and peripheral blood eosinophilia. Urine sediment usually reveals white cells, red cells, and white cell casts. Urinary eosinophils may be present, but this test lacks the specificity and sensitivity to either exclude or diagnose AIN. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute interstitial nephritis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Eosinophilic cystitis</strong> &ndash; Eosinophilic cystitis presents with hematuria, urinary frequency, dysuria, and suprapubic pain [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/88\" class=\"abstract_t\">88</a>]. It occurs more often in children than adults and is of unknown etiology [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/89\" class=\"abstract_t\">89</a>]. Cystoscopy reveals diffusely hyperemic mucosa with nodular areas of prominent eosinophilic infiltration [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/90\" class=\"abstract_t\">90</a>]. The diagnosis is confirmed histologically; bladder carcinoma is the principal alternative diagnosis. Although most patients have a benign course with spontaneous resolution, some chronic cases progress to bladder destruction and renal failure [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/91\" class=\"abstract_t\">91</a>]. A variety of treatments can be considered including fulguration, analgesics, or glucocorticoids [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/92\" class=\"abstract_t\">92</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Dialysis</strong> &ndash; Patients on hemodialysis may have mild eosinophilia [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/93\" class=\"abstract_t\">93</a>]. Initiation of peritoneal dialysis leads to episodes of peritoneal eosinophilia with or without blood eosinophilia [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/94,95\" class=\"abstract_t\">94,95</a>]. Although this eosinophilic peritonitis is usually self-limited, treatment with <a href=\"topic.htm?path=montelukast-drug-information\" class=\"drug drug_general\">montelukast</a> has been described [<a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/96\" class=\"abstract_t\">96</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Transplant rejection</strong> &ndash; Infiltration of eosinophils may accompany rejection of transplanted kidneys, and blood and urinary eosinophil counts are variably monitored as indicators of rejection. (See <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-acute-renal-allograft-rejection\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of acute renal allograft rejection&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H261624410\"><span class=\"h2\">Neurologic</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The combination of neurologic findings and eosinophilia may be seen in the hypereosinophilic syndromes, EGPA, and with eosinophilic meningitis. (See <a href=\"topic.htm?path=eosinophilic-meningitis\" class=\"medical medical_review\">&quot;Eosinophilic meningitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H17149570\"><span class=\"h1\">SUMMARY</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eosinophils are predominantly tissue-dwelling cells whose functions in health are not entirely understood. Eosinophil numbers increase in a variety disease states, ranging in severity from mild to life-threatening. When activated, eosinophils can release mediators and substances that can damage tissues and contribute to disease pathology. (See <a href=\"#H199339678\" class=\"local\">'Eosinophil biology'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In peripheral blood, an absolute eosinophil count (determined by multiplying the total white blood cell count by the percentage of eosinophils) of 0 to 500 <span class=\"nowrap\">cells/microL</span> (&lt;0.5 x 10<sup>9</sup><span class=\"nowrap\">/L)</span> is typically considered normal. (See <a href=\"#H347120257\" class=\"local\">'Normal levels'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An increase in eosinophils in the peripheral blood or tissues most commonly represents a reactive or secondary expansion of a polyclonal eosinophil population. Less commonly, eosinophilia can be clonal, resulting from a hematopoietic stem cell mutation. (See <a href=\"#H17149701\" class=\"local\">'Mechanisms of eosinophilia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Tissue damage is more likely to occur when the absolute eosinophil count exceeds 1500 <span class=\"nowrap\">cells/microL,</span> but it can also occur with lower blood eosinophil levels. It is important to understand that <strong>the degree of peripheral blood eosinophilia does not always accurately predict the risk of organ damage.</strong> (See <a href=\"#H199339794\" class=\"local\">'Tissue damage'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>In eosinophilic diseases, the skin, airways, and gastrointestinal tract are common target organs. The heart and nervous system can also be infiltrated, and damage to these organs is potentially life-threatening. (See <a href=\"#H199339842\" class=\"local\">'Target organs'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Causes of eosinophilia may be divided into those disorders that cause signs and symptoms in multiple organ systems, accompanied by peripheral eosinophilia (<a href=\"image.htm?imageKey=ID%2F76434\" class=\"graphic graphic_table graphicRef76434 \">table 1</a>), and those disorders that predominantly affect one organ system, with variable peripheral eosinophilia (<a href=\"image.htm?imageKey=ID%2F84016\" class=\"graphic graphic_table graphicRef84016 \">table 2</a>). (See <a href=\"#H199339848\" class=\"local\">'Major causes of eosinophilia'</a> above and <a href=\"#H261622134\" class=\"local\">'Disorders with eosinophilic involvement of specific organs'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The degree of eosinophilia is rarely helpful for identifying the cause, except at extremes of eosinophil counts (eg, very mild eosinophilia is more likely to be seen with asthma or allergic rhinitis; very severe eosinophilia [ie, &ge;20,000 <span class=\"nowrap\">eosinophils/microL]</span> is more likely to be caused by a myeloid neoplasm). Between these two extremes, there is a wide differential of potential etiologies. (See <a href=\"#H347121734\" class=\"local\">'Importance of considering many possible causes'</a> above.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/1\" class=\"nounderline abstract_t\">Gleich GJ, Klion AD, Lee JJ, Weller PF. The consequences of not having eosinophils. Allergy 2013; 68:829.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/2\" class=\"nounderline abstract_t\">Roufosse F, Weller PF. Practical approach to the patient with hypereosinophilia. J Allergy Clin Immunol 2010; 126:39.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/3\" class=\"nounderline abstract_t\">Ackerman SJ, Bochner BS. Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol Allergy Clin North Am 2007; 27:357.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/4\" class=\"nounderline abstract_t\">Hsieh MM, Everhart JE, Byrd-Holt DD, et al. Prevalence of neutropenia in the U.S. population: age, sex, smoking status, and ethnic differences. Ann Intern Med 2007; 146:486.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/5\" class=\"nounderline abstract_t\">Spector SL, Tan RA. Is a single blood eosinophil count a reliable marker for &quot;eosinophilic asthma?&quot;. J Asthma 2012; 49:807.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/6\" class=\"nounderline abstract_t\">Statland BE, Winkel P, Harris SC, et al. Evaluation of biologic sources of variation of leukocyte counts and other hematologic quantities using very precise automated analyzers. Am J Clin Pathol 1978; 69:48.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/7\" class=\"nounderline abstract_t\">Sennels HP, J&oslash;rgensen HL, Hansen AL, et al. Diurnal variation of hematology parameters in healthy young males: the Bispebjerg study of diurnal variations. Scand J Clin Lab Invest 2011; 71:532.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/8\" class=\"nounderline abstract_t\">Weller PF. The immunobiology of eosinophils. N Engl J Med 1991; 324:1110.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/9\" class=\"nounderline abstract_t\">Liu Z, Liu Q, Pesce J, et al. Requirements for the development of IL-4-producing T cells during intestinal nematode infections: what it takes to make a Th2 cell in vivo. Immunol Rev 2004; 201:57.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/10\" class=\"nounderline abstract_t\">Moore TA, Nutman TB. Eosinophilia in the returning traveler. Infect Dis Clin North Am 1998; 12:503.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/11\" class=\"nounderline abstract_t\">Roediger B, Weninger W. Group 2 innate lymphoid cells in the regulation of immune responses. Adv Immunol 2015; 125:111.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/12\" class=\"nounderline abstract_t\">Chen YY, Khoury P, Ware JM, et al. Marked and persistent eosinophilia in the absence of clinical manifestations. J Allergy Clin Immunol 2014; 133:1195.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/13\" class=\"nounderline abstract_t\">Helbig G, Hus M, Francuz T, et al. Characteristics and clinical outcome of patients with hypereosinophilia of undetermined significance. Med Oncol 2014; 31:815.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/14\" class=\"nounderline abstract_t\">Makiya MA, Herrick JA, Khoury P, et al. Development of a suspension array assay in multiplex for the simultaneous measurement of serum levels of four eosinophil granule proteins. J Immunol Methods 2014; 411:11.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/15\" class=\"nounderline abstract_t\">Gotlib J. World Health Organization-defined eosinophilic disorders: 2017 update on diagnosis, risk stratification, and management. Am J Hematol 2017; 92:1243.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/16\" class=\"nounderline abstract_t\">Navarro-Rom&aacute;n L, Medeiros LJ, Kingma DW, et al. Malignant lymphomas of B-cell lineage with marked tissue eosinophilia. A report of five cases. Am J Surg Pathol 1994; 18:347.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/17\" class=\"nounderline abstract_t\">Robyn J, Noel P, Wlodarska I, et al. Imatinib-responsive hypereosinophilia in a patient with B cell ALL. Leuk Lymphoma 2004; 45:2497.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/18\" class=\"nounderline abstract_t\">Toboso DG, Campos CB. Peripheral eosinophilia as the first manifestation of B-cell acute lymphoblastic leukemia with t(5;14)(q31;q32). Blood 2017; 130:380.</a></li><li class=\"breakAll\">Wilson ME, Weller PF. Eosinophilia. In: Tropical Infectious Diseases: Principles, Pathogens and Practice, 3rd ed, Guerrant RL, Walker DH, Weller PF (Eds), Saunders Elsevier, Philadelphia 2011. p.939.</li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/20\" class=\"nounderline abstract_t\">Ottesen EA, Weller PF. Eosinophilia following treatment of patients with schistosomiasis mansoni and Bancroft's filariasis. J Infect Dis 1979; 139:343.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/21\" class=\"nounderline abstract_t\">Reimert CM, Fitzsimmons CM, Joseph S, et al. Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel. Clin Vaccine Immunol 2006; 13:584.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/22\" class=\"nounderline abstract_t\">Sluzevich JC, Sheth AP, Lucky AW. Persistent eosinophilia as a presenting sign of scabies in patients with disorders of keratinization. Arch Dermatol 2007; 143:670.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/23\" class=\"nounderline abstract_t\">Roberts LJ, Huffam SE, Walton SF, Currie BJ. Crusted scabies: clinical and immunological findings in seventy-eight patients and a review of the literature. J Infect 2005; 50:375.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/24\" class=\"nounderline abstract_t\">Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis 1994; 18:627.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/25\" class=\"nounderline abstract_t\">Malo J, Luraschi-Monjagatta C, Wolk DM, et al. Update on the diagnosis of pulmonary coccidioidomycosis. Ann Am Thorac Soc 2014; 11:243.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/26\" class=\"nounderline abstract_t\">Simons CM, Stratton CW, Kim AS. Peripheral blood eosinophilia as a clue to the diagnosis of an occult Coccidioides infection. Hum Pathol 2011; 42:449.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/27\" class=\"nounderline abstract_t\">Kaplan MH, Hall WW, Susin M, et al. Syndrome of severe skin disease, eosinophilia, and dermatopathic lymphadenopathy in patients with HTLV-II complicating human immunodeficiency virus infection. Am J Med 1991; 91:300.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/28\" class=\"nounderline abstract_t\">Plumelle Y, Gonin C, Edouard A, et al. Effect of Strongyloides stercoralis infection and eosinophilia on age at onset and prognosis of adult T-cell leukemia. Am J Clin Pathol 1997; 107:81.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/29\" class=\"nounderline abstract_t\">Esposito DH, Stich A, Epelboin L, et al. Acute muscular sarcocystosis: an international investigation among ill travelers returning from Tioman Island, Malaysia, 2011-2012. Clin Infect Dis 2014; 59:1401.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/30\" class=\"nounderline abstract_t\">Saric M, Kronzon I. Cholesterol embolization syndrome. Curr Opin Cardiol 2011; 26:472.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/31\" class=\"nounderline abstract_t\">Kim YJ, Dale JK, Noel P, et al. Eosinophilia is associated with a higher mortality rate among patients with autoimmune lymphoproliferative syndrome. Am J Hematol 2007; 82:615.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/32\" class=\"nounderline abstract_t\">Turul T, Tezcan I, Artac H, et al. Clinical heterogeneity can hamper the diagnosis of patients with ZAP70 deficiency. Eur J Pediatr 2009; 168:87.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/33\" class=\"nounderline abstract_t\">Klion A. Hypereosinophilic syndrome: current approach to diagnosis and treatment. Annu Rev Med 2009; 60:293.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/34\" class=\"nounderline abstract_t\">Adame J, Cohen PR. Eosinophilic panniculitis: diagnostic considerations and evaluation. J Am Acad Dermatol 1996; 34:229.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/35\" class=\"nounderline abstract_t\">Glass LA, Zaghloul AB, Solomon AR. Eosinophilic panniculitis associated with chronic recurrent parotitis. Am J Dermatopathol 1989; 11:555.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/36\" class=\"nounderline abstract_t\">Kato N. Eosinophilic panniculitis. J Dermatol 1993; 20:185.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/37\" class=\"nounderline abstract_t\">Shan SJ, Guo Y. Exenatide-induced eosinophilic sclerosing lipogranuloma at the injection site. Am J Dermatopathol 2014; 36:510.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/38\" class=\"nounderline abstract_t\">Batalla A, Ros&oacute;n E, Posada C, Fl&oacute;rez A. Eosinophilic panniculitis after subcutaneous administration of sodium heparin. Indian J Dermatol Venereol Leprol 2013; 79:849.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/39\" class=\"nounderline abstract_t\">Masferrer E, Martin-Ezquerra G, Mart&iacute;nez-Escala E, et al. Eosinophilic panniculitis triggered by intramuscular penicillin and occupational setting. Allergy 2011; 66:436.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/40\" class=\"nounderline abstract_t\">Don DM, Ishiyama A, Johnstone AK, et al. Angiolymphoid hyperplasia with eosinophilia and vascular tumors of the head and neck. Am J Otolaryngol 1996; 17:240.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/41\" class=\"nounderline abstract_t\">Helander SD, Peters MS, Kuo TT, Su WP. Kimura's disease and angiolymphoid hyperplasia with eosinophilia: new observations from immunohistochemical studies of lymphocyte markers, endothelial antigens, and granulocyte proteins. J Cutan Pathol 1995; 22:319.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/42\" class=\"nounderline abstract_t\">Chen H, Thompson LD, Aguilera NS, Abbondanzo SL. Kimura disease: a clinicopathologic study of 21 cases. Am J Surg Pathol 2004; 28:505.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/43\" class=\"nounderline abstract_t\">Ma XR, Xin SJ, Ouyang TX, et al. Successful treatment of Kimura's disease with leflunomide and methylprednisolone: a case report. Int J Clin Exp Med 2014; 7:2219.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/44\" class=\"nounderline abstract_t\">Ben-Chetrit E, Amir G, Shalit M. Cetirizine: An effective agent in Kimura's disease. Arthritis Rheum 2005; 53:117.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/45\" class=\"nounderline abstract_t\">Chang AR, Kim K, Kim HJ, et al. Outcomes of Kimura's disease after radiotherapy or nonradiotherapeutic treatment modalities. Int J Radiat Oncol Biol Phys 2006; 65:1233.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/46\" class=\"nounderline abstract_t\">Singh S, Dayal M, Walia R, et al. Intralesional radiofrequency ablation for nodular angiolymphoid hyperplasia on forehead: a minimally invasive approach. Indian J Dermatol Venereol Leprol 2014; 80:419.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/47\" class=\"nounderline abstract_t\">Nouchi A, Hickman G, Battistella M, et al. [Treatment of angiolymphoid hyperplasia with eosinophilia (ALHE) using topical tacrolimus: Two cases]. Ann Dermatol Venereol 2015; 142:360.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/48\" class=\"nounderline abstract_t\">Rongioletti F, Cecchi F, Pastorino C, Scaparro M. Successful management of refractory angiolymphoid hyperplasia with eosinophilia with thalidomide. J Eur Acad Dermatol Venereol 2016; 30:527.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/49\" class=\"nounderline abstract_t\">Aberer W, Konrad K, Wolff K. Wells' syndrome is a distinctive disease entity and not a histologic diagnosis. J Am Acad Dermatol 1988; 18:105.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/50\" class=\"nounderline abstract_t\">Caputo R, Marzano AV, Vezzoli P, Lunardon L. Wells syndrome in adults and children: a report of 19 cases. Arch Dermatol 2006; 142:1157.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/51\" class=\"nounderline abstract_t\">Beer TW, Langtry JA, Phillips WG, Wojnarowska F. Flame figures in bullous pemphigoid. Dermatology 1994; 188:310.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/52\" class=\"nounderline abstract_t\">Falagas ME, Vergidis PI. Narrative review: diseases that masquerade as infectious cellulitis. Ann Intern Med 2005; 142:47.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/53\" class=\"nounderline abstract_t\">Sinno H, Lacroix JP, Lee J, et al. Diagnosis and management of eosinophilic cellulitis (Wells' syndrome): A case series and literature review. Can J Plast Surg 2012; 20:91.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/54\" class=\"nounderline abstract_t\">Singanayagam A, Lamb L, Makinde JE, et al. Systemic cytokine storm in severe eosinophilic dermatitis. QJM 2015; 108:907.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/55\" class=\"nounderline abstract_t\">Ota M, Shimizu T, Hashino S, Shimizu H. Eosinophilic folliculitis in a patient after allogeneic bone marrow transplantation: case report and review of the literature. Am J Hematol 2004; 76:295.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/56\" class=\"nounderline abstract_t\">Hern&aacute;ndez-Mart&iacute;n &Aacute;, Nu&ntilde;o-Gonz&aacute;lez A, Colmenero I, Torrelo A. Eosinophilic pustular folliculitis of infancy: a series of 15 cases and review of the literature. J Am Acad Dermatol 2013; 68:150.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/57\" class=\"nounderline abstract_t\">Chen KR, Su WP, Pittelkow MR, Leiferman KM. Eosinophilic vasculitis syndrome: recurrent cutaneous eosinophilic necrotizing vasculitis. Semin Dermatol 1995; 14:106.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/58\" class=\"nounderline abstract_t\">Li W, Cao W, Song H, et al. Recurrent cutaneous necrotizing eosinophilic vasculitis: a case report and review of the literature. Diagn Pathol 2013; 8:185.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/59\" class=\"nounderline abstract_t\">Launay D, Delaporte E, Gillot JM, et al. An unusual cause of vascular purpura: recurrent cutaneous eosinophilic necrotizing vasculitis. Acta Derm Venereol 2000; 80:394.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/60\" class=\"nounderline abstract_t\">el-Mofty SK, Swanson PE, Wick MR, Miller AS. Eosinophilic ulcer of the oral mucosa. Report of 38 new cases with immunohistochemical observations. Oral Surg Oral Med Oral Pathol 1993; 75:716.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/61\" class=\"nounderline abstract_t\">Damevska K, Gocev G, Nikolovska S. Eosinophilic ulcer of the oral mucosa: report of a case with multiple synchronous lesions. Am J Dermatopathol 2014; 36:594.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/62\" class=\"nounderline abstract_t\">Segura S, Pujol RM. Eosinophilic ulcer of the oral mucosa: a distinct entity or a non-specific reactive pattern? Oral Dis 2008; 14:287.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/63\" class=\"nounderline abstract_t\">Segura S, Romero D, Mascar&oacute; JM Jr, et al. Eosinophilic ulcer of the oral mucosa: another histological simulator of CD30+ lymphoproliferative disorders. Br J Dermatol 2006; 155:460.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/64\" class=\"nounderline abstract_t\">McEvoy MT, Peterson EA, Kobza-Black A, et al. Immunohistological comparison of granulated cell proteins in induced immediate urticarial dermographism and delayed pressure urticaria lesions. Br J Dermatol 1995; 133:853.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/65\" class=\"nounderline abstract_t\">Noguchi H, Kephart GM, Campbell RJ, et al. Tissue eosinophilia and eosinophil degranulation in orbital pseudotumor. Ophthalmology 1991; 98:928.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/66\" class=\"nounderline abstract_t\">Zenarola P, Melillo L, Bisceglia M, et al. NERDS syndrome: an additional case report. Dermatology 1995; 191:133.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/67\" class=\"nounderline abstract_t\">Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/68\" class=\"nounderline abstract_t\">Winter HS, Madara JL, Stafford RJ, et al. Intraepithelial eosinophils: a new diagnostic criterion for reflux esophagitis. Gastroenterology 1982; 83:818.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/69\" class=\"nounderline abstract_t\">Brown LF, Goldman H, Antonioli DA. Intraepithelial eosinophils in endoscopic biopsies of adults with reflux esophagitis. Am J Surg Pathol 1984; 8:899.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/70\" class=\"nounderline abstract_t\">Karttunen TJ, Niemel&auml; S, Kerola T. Blood leukocyte differential in Helicobacter pylori infection. Dig Dis Sci 1996; 41:1332.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/71\" class=\"nounderline abstract_t\">Bischoff SC, Wedemeyer J, Herrmann A, et al. Quantitative assessment of intestinal eosinophils and mast cells in inflammatory bowel disease. Histopathology 1996; 28:1.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/72\" class=\"nounderline abstract_t\">Ettinghausen SE. Collagenous colitis, eosinophilic colitis, and neutropenic colitis. Surg Clin North Am 1993; 73:993.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/73\" class=\"nounderline abstract_t\">Yamazaki K, Nakadate I, Suzuki K, et al. Eosinophilia in primary biliary cirrhosis. Am J Gastroenterol 1996; 91:516.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/74\" class=\"nounderline abstract_t\">Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood 1994; 83:2759.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/75\" class=\"nounderline abstract_t\">Dillon JF, Finlayson ND. Idiopathic hypereosinophilic syndrome presenting as intrahepatic cholestatic jaundice. Am J Gastroenterol 1994; 89:1254.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/76\" class=\"nounderline abstract_t\">Grauer L, Padilla VM 3rd, Bouza L, Barkin JS. Eosinophilic sclerosing cholangitis associated with hypereosinophilic syndrome. Am J Gastroenterol 1993; 88:1764.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/77\" class=\"nounderline abstract_t\">Rosengart TK, Rotterdam H, Ranson JH. Eosinophilic cholangitis: a self-limited cause of extrahepatic biliary obstruction. Am J Gastroenterol 1990; 85:582.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/78\" class=\"nounderline abstract_t\">Dabbs DJ. Eosinophilic and lymphoeosinophilic cholecystitis. Am J Surg Pathol 1993; 17:497.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/79\" class=\"nounderline abstract_t\">Kendell KR, Day JD, Hruban RH, et al. Intimate association of eosinophils to collagen bundles in eosinophilic myocarditis and ranitidine-induced hypersensitivity myocarditis. Arch Pathol Lab Med 1995; 119:1154.</a></li><li class=\"breakAll\">Spry CJF. A Comprehensive Review and Guide to the Scientific and Medical Literature, Oxford Medical Publications, Oxford 1988.</li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/81\" class=\"nounderline abstract_t\">Monsuez JJ, de Kerviler E, Barboteu M, et al. Non-Hodgkin's lymphoma related eosinophilic endomyocardial disease. Eur Heart J 1994; 15:1423.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/82\" class=\"nounderline abstract_t\">Donhuijsen K, Haedicke C, Hattenberger S, et al. Granulocyte-macrophage colony-stimulating factor-related eosinophilia and Loeffler's endocarditis. Blood 1992; 79:2798.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/83\" class=\"nounderline abstract_t\">Date A, Jacob M, Johny KV. Eosinophilic leukocytes in diffuse proliferative and exudative glomerulonephritis. Am J Trop Med Hyg 1977; 26:1028.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/84\" class=\"nounderline abstract_t\">Liu S, Miller PD, Holmes SA, et al. Eosinophilic prostatitis and prostatic specific antigen. Br J Urol 1992; 69:61.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/85\" class=\"nounderline abstract_t\">Lowe D, Fletcher CD, Gower RL. Tumour-associated eosinophilia in the bladder. J Clin Pathol 1984; 37:500.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/86\" class=\"nounderline abstract_t\">Nolan CR 3rd, Anger MS, Kelleher SP. Eosinophiluria--a new method of detection and definition of the clinical spectrum. N Engl J Med 1986; 315:1516.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/87\" class=\"nounderline abstract_t\">Eltoum IA, Ghalib HW, Sualaiman S, et al. Significance of eosinophiluria in urinary schistosomiasis. A study using Hansel's stain and electron microscopy. Am J Clin Pathol 1989; 92:329.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/88\" class=\"nounderline abstract_t\">Mosholt KS, Dahl C, Azawi NH. Eosinophilic cystitis: three cases, and a review over 10 years. BMJ Case Rep 2014; 2014.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/89\" class=\"nounderline abstract_t\">Fuller TW, Dangle P, Reese JN, et al. Inflammatory myofibroblastic tumor of the bladder masquerading as eosinophilic cystitis: case report and review of the literature. Urology 2015; 85:921.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/90\" class=\"nounderline abstract_t\">Li G, Cai B, Song H, Yang Z. Clinical and radiological character of eosinophilic cystitis. Int J Clin Exp Med 2015; 8:533.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/91\" class=\"nounderline abstract_t\">Itano NM, Malek RS. Eosinophilic cystitis in adults. J Urol 2001; 165:805.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/92\" class=\"nounderline abstract_t\">Kili&ccedil; S, Erguvan R, Ipek D, et al. Eosinophilic cystitis. A rare inflammatory pathology mimicking bladder neoplasms. Urol Int 2003; 71:285.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/93\" class=\"nounderline abstract_t\">Lee CC, Leu ML, Kuo HP, Huang CC. Hypereosinophilia in hemodialysis patients. Changgeng Yi Xue Za Zhi 1995; 18:20.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/94\" class=\"nounderline abstract_t\">Chan MK, Chow L, Lam SS, Jones B. Peritoneal eosinophilia in patients on continuous ambulatory peritoneal dialysis: a prospective study. Am J Kidney Dis 1988; 11:180.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/95\" class=\"nounderline abstract_t\">Patel UO, Fox SR, Moy JN, Korbet SM. Pruritic rash and eosinophilia in a patient receiving peritoneal dialysis. Semin Dial 2011; 24:338.</a></li><li><a href=\"https://www.uptodate.com/contents/eosinophil-biology-and-causes-of-eosinophilia/abstract/96\" class=\"nounderline abstract_t\">Forbes TA, Lunn AJ. Montelukast: a novel therapeutic option in eosinophilic peritonitis. Pediatr Nephrol 2014; 29:1279.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 100544 Version 10.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H17149570\"><span>SUMMARY</span></a></li><li><a href=\"#H17149461\" id=\"outline-link-H17149461\">INTRODUCTION</a></li><li><a href=\"#H199339678\" id=\"outline-link-H199339678\">EOSINOPHIL BIOLOGY</a><ul><li><a href=\"#H347120257\" id=\"outline-link-H347120257\">Normal levels</a></li><li><a href=\"#H17149701\" id=\"outline-link-H17149701\">Mechanisms of eosinophilia</a></li><li><a href=\"#H199339794\" id=\"outline-link-H199339794\">Tissue damage</a><ul><li><a href=\"#H199339842\" id=\"outline-link-H199339842\">- Target organs</a></li></ul></li></ul></li><li><a href=\"#H199339848\" id=\"outline-link-H199339848\">MAJOR CAUSES OF EOSINOPHILIA</a><ul><li><a href=\"#H347121734\" id=\"outline-link-H347121734\">Importance of considering many possible causes</a><ul><li><a href=\"#H199339877\" id=\"outline-link-H199339877\">- Neoplastic diseases</a></li><li><a href=\"#H199340137\" id=\"outline-link-H199340137\">- Parasites and other infections</a><ul><li><a href=\"#H199340240\" id=\"outline-link-H199340240\">Parasites to consider in all patients</a></li><li><a href=\"#H199340318\" id=\"outline-link-H199340318\">Infections relevant to certain geographic areas</a></li><li><a href=\"#H199340385\" id=\"outline-link-H199340385\">Nonhelminthic infections</a></li></ul></li><li><a href=\"#H199340657\" id=\"outline-link-H199340657\">- Allergic disorders</a><ul><li><a href=\"#H347120666\" id=\"outline-link-H347120666\">Organ-specific allergic disorders</a></li><li><a href=\"#H347120672\" id=\"outline-link-H347120672\">Drug reactions</a></li></ul></li><li><a href=\"#H199340932\" id=\"outline-link-H199340932\">- Adrenal insufficiency</a></li><li><a href=\"#H199340960\" id=\"outline-link-H199340960\">- Connective tissue/rheumatologic diseases</a></li><li><a href=\"#H199341010\" id=\"outline-link-H199341010\">- Other rare causes</a></li></ul></li></ul></li><li><a href=\"#H261622134\" id=\"outline-link-H261622134\">DISORDERS WITH EOSINOPHILIC INVOLVEMENT OF SPECIFIC ORGANS</a><ul><li><a href=\"#H261623233\" id=\"outline-link-H261623233\">Dermatologic</a></li><li><a href=\"#H261623754\" id=\"outline-link-H261623754\">Sinonasal and pulmonary</a></li><li><a href=\"#H261623906\" id=\"outline-link-H261623906\">Gastrointestinal and hepatobiliary</a></li><li><a href=\"#H261624150\" id=\"outline-link-H261624150\">Cardiac</a></li><li><a href=\"#H261624250\" id=\"outline-link-H261624250\">Renal</a></li><li><a href=\"#H261624410\" id=\"outline-link-H261624410\">Neurologic</a></li></ul></li><li><a href=\"#H17149570\" id=\"outline-link-H17149570\">SUMMARY</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"HEME/100544|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=RHEUM/63025\" class=\"graphic graphic_picture\">- Urticaria pigmentosa</a></li><li><a href=\"image.htm?imageKey=DERM/86763\" class=\"graphic graphic_picture\">- DRESS rash 1</a></li><li><a href=\"image.htm?imageKey=DERM/86859\" class=\"graphic graphic_picture\">- Drug reaction with eosinophilia and systemic symptoms 2</a></li><li><a href=\"image.htm?imageKey=DERM/86860\" class=\"graphic graphic_picture\">- Drug reaction with eosinophilia and systemic symptoms 3</a></li><li><a href=\"image.htm?imageKey=RHEUM/65829\" class=\"graphic graphic_picture\">- Skin in eosinophilic fasciitis</a></li><li><a href=\"image.htm?imageKey=HEME/87394\" class=\"graphic graphic_picture\">- Eosinophilic cellulitis</a></li><li><a href=\"image.htm?imageKey=DERM/87125\" class=\"graphic graphic_picture\">- HIV-associated eosinophilic folliculitis</a></li><li><a href=\"image.htm?imageKey=DERM/54404\" class=\"graphic graphic_picture\">- Eosinophilic folliculitis B</a></li></ul></li><li><div id=\"HEME/100544|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=ID/76434\" class=\"graphic graphic_table\">- Eosinophil-associated diseases</a></li><li><a href=\"image.htm?imageKey=ID/84016\" class=\"graphic graphic_table\">- Diseases with organ eosinophils</a></li><li><a href=\"image.htm?imageKey=ID/82384\" class=\"graphic graphic_table\">- Helminths with marked eosinophilia</a></li><li><a href=\"image.htm?imageKey=ID/59981\" class=\"graphic graphic_table\">- Helminths with prolonged eos</a></li><li><a href=\"image.htm?imageKey=ID/84014\" class=\"graphic graphic_table\">- Helminths with eosinophilia</a></li><li><a href=\"image.htm?imageKey=ID/84015\" class=\"graphic graphic_table\">- Drugs and eosinophilia</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=allergic-fungal-rhinosinusitis\" class=\"medical medical_review\">Allergic fungal rhinosinusitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=allergic-rhinitis-clinical-manifestations-epidemiology-and-diagnosis\" class=\"medical medical_review\">Allergic rhinitis: Clinical manifestations, epidemiology, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=approach-to-the-patient-with-unexplained-eosinophilia\" class=\"medical medical_review\">Approach to the patient with unexplained eosinophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=aspirin-exacerbated-respiratory-disease\" class=\"medical medical_review\">Aspirin-exacerbated respiratory disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=atopic-dermatitis-eczema-pathogenesis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Atopic dermatitis (eczema): Pathogenesis, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-lymphoproliferative-syndrome-alps-clinical-features-and-diagnosis\" class=\"medical medical_review\">Autoimmune lymphoproliferative syndrome (ALPS): Clinical features and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autoimmune-lymphoproliferative-syndrome-alps-epidemiology-and-pathogenesis\" class=\"medical medical_review\">Autoimmune lymphoproliferative syndrome (ALPS): Epidemiology and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=autosomal-dominant-hyperimmunoglobulin-e-syndrome\" class=\"medical medical_review\">Autosomal dominant hyperimmunoglobulin E syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=causes-of-pulmonary-eosinophilia\" class=\"medical medical_review\">Causes of pulmonary eosinophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-eosinophilic-pneumonia\" class=\"medical medical_review\">Chronic eosinophilic pneumonia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=chronic-rhinosinusitis-clinical-manifestations-pathophysiology-and-diagnosis\" class=\"medical medical_review\">Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-acute-renal-allograft-rejection\" class=\"medical medical_review\">Clinical features and diagnosis of acute renal allograft rejection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss\" class=\"medical medical_review\">Clinical features and diagnosis of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-interstitial-nephritis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acute interstitial nephritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-allergic-bronchopulmonary-aspergillosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of allergic bronchopulmonary aspergillosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-chronic-myeloid-leukemia\" class=\"medical medical_review\">Clinical manifestations and diagnosis of chronic myeloid leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-eosinophilic-esophagitis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of eosinophilic esophagitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-adrenal-insufficiency-in-adults\" class=\"medical medical_review\">Clinical manifestations of adrenal insufficiency in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-acute-myeloid-leukemia\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-angioimmunoblastic-t-cell-lymphoma\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of angioimmunoblastic T cell lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-peripheral-t-cell-lymphoma-not-otherwise-specified\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of peripheral T cell lymphoma, not otherwise specified</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-pathologic-features-and-diagnosis-of-precursor-b-cell-acute-lymphoblastic-leukemia-lymphoma\" class=\"medical medical_review\">Clinical manifestations, pathologic features, and diagnosis of precursor B cell acute lymphoblastic leukemia/lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-non-hodgkin-lymphoma\" class=\"medical medical_review\">Clinical presentation and diagnosis of non-Hodgkin lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-pathologic-features-and-diagnosis-of-sezary-syndrome\" class=\"medical medical_review\">Clinical presentation, pathologic features, and diagnosis of S&eacute;zary syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=combined-immunodeficiencies\" class=\"medical medical_review\">Combined immunodeficiencies</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cytogenetics-in-acute-myeloid-leukemia\" class=\"medical medical_review\">Cytogenetics in acute myeloid leukemia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-of-adrenal-insufficiency-in-adults\" class=\"medical medical_review\">Diagnosis of adrenal insufficiency in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=drug-reaction-with-eosinophilia-and-systemic-symptoms-dress\" class=\"medical medical_review\">Drug reaction with eosinophilia and systemic symptoms (DRESS)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=embolism-from-atherosclerotic-plaque-atheroembolism-cholesterol-crystal-embolism\" class=\"medical medical_review\">Embolism from atherosclerotic plaque: Atheroembolism (cholesterol crystal embolism)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=eosinophilic-fasciitis\" class=\"medical medical_review\">Eosinophilic fasciitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=eosinophilic-gastroenteritis\" class=\"medical medical_review\">Eosinophilic gastroenteritis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=eosinophilic-meningitis\" class=\"medical medical_review\">Eosinophilic meningitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-manifestations-of-schistosomiasis\" class=\"medical medical_review\">Epidemiology, pathogenesis, and clinical manifestations of schistosomiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-and-pathology-of-eosinophilic-granulomatosis-with-polyangiitis-churg-strauss\" class=\"medical medical_review\">Epidemiology, pathogenesis, and pathology of eosinophilic granulomatosis with polyangiitis (Churg-Strauss)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-and-pathogenesis-of-myocarditis\" class=\"medical medical_review\">Etiology and pathogenesis of myocarditis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-severe-asthma-in-adolescents-and-adults\" class=\"medical medical_review\">Evaluation of severe asthma in adolescents and adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evaluation-of-wheezing-illnesses-other-than-asthma-in-adults\" class=\"medical medical_review\">Evaluation of wheezing illnesses other than asthma in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hiv-associated-eosinophilic-folliculitis\" class=\"medical medical_review\">HIV-associated eosinophilic folliculitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hookworm-infection\" class=\"medical medical_review\">Hookworm infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypereosinophilic-syndromes-clinical-manifestations-pathophysiology-and-diagnosis\" class=\"medical medical_review\">Hypereosinophilic syndromes: Clinical manifestations, pathophysiology, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hypereosinophilic-syndromes-treatment\" class=\"medical medical_review\">Hypereosinophilic syndromes: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ipex-immune-dysregulation-polyendocrinopathy-enteropathy-x-linked\" class=\"medical medical_review\">IPEX: Immune dysregulation, polyendocrinopathy, enteropathy, X-linked</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=liver-transplantation-diagnosis-of-acute-cellular-rejection\" class=\"medical medical_review\">Liver transplantation: Diagnosis of acute cellular rejection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphatic-filariasis-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mansonella-infections\" class=\"medical medical_review\">Mansonella infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-evaluation-and-diagnosis-in-adults\" class=\"medical medical_review\">Mastocytosis (cutaneous and systemic): Evaluation and diagnosis in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pituitary-and-adrenal-gland-dysfunction-in-hiv-infected-patients\" class=\"medical medical_review\">Pituitary and adrenal gland dysfunction in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pleural-fluid-eosinophilia\" class=\"medical medical_review\">Pleural fluid eosinophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-coccidioidal-infection\" class=\"medical medical_review\">Primary coccidioidal infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=risk-factors-for-and-possible-causes-of-systemic-sclerosis-scleroderma\" class=\"medical medical_review\">Risk factors for and possible causes of systemic sclerosis (scleroderma)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=strongyloidiasis\" class=\"medical medical_review\">Strongyloidiasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-significance-of-urinary-eosinophils\" class=\"medical medical_review\">The significance of urinary eosinophils</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=toxocariasis-visceral-and-ocular-larva-migrans\" class=\"medical medical_review\">Toxocariasis: Visceral and ocular larva migrans</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=trichinellosis\" class=\"medical medical_review\">Trichinellosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tropical-pulmonary-eosinophilia\" class=\"medical medical_review\">Tropical pulmonary eosinophilia</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=zap-70-deficiency\" class=\"medical medical_review\">ZAP-70 deficiency</a></li></ul></div></div>","javascript":null}